Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
Duo 1989 Preliminary study of biochemical constitutions of berry of sea buckthorn growing in Shanxi province and their changing trend
Clinical studies show that users of Semaglutide lose an average of 15% of their body weight over time
Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
One of the biggest differences was how many people reached higher levels of weight loss: about 1 in 3 people taking Wegovy 7.2 mg lost 25% or more of their body weight during the study
A case of spontaneous basal ganglia hemorrhage with contralateral extension utilizing the canal of Gratiolet
